Can Fatty Liver Cause Blurry Vision?

Fatty liver disease and blurry vision may seem unrelated, but emerging evidence suggests a meaningful connection through shared metabolic pathways. Can fatty liver cause blurry vision? Not directly, but the systemic consequences of hepatic steatosis, including chronic inflammation, nutritional deficiencies, and coexisting conditions such as type 2 diabetes and metabolic syndrome, can affect the delicate structures of the eye. Understanding how liver health influences ocular health is important for anyone living with non-alcoholic fatty liver disease (NAFLD), and knowing when to seek medical advice could help protect both your liver and your sight.

Can fatty liver really affect your eyesight?

Fatty liver disease can indirectly affect eyesight through systemic metabolic changes, inflammation, and coexisting conditions such as diabetes, rather than through a single direct mechanism.

Fatty liver disease can be associated with visual disturbances, including blurry vision, although the relationship is indirect rather than a direct cause-and-effect mechanism. Fatty liver disease, known medically as hepatic steatosis, encompasses a spectrum from simple fat accumulation in liver cells through to non-alcoholic steatohepatitis (NASH) and, in more advanced cases, cirrhosis. While the liver itself does not control vision, the metabolic and systemic consequences of liver disease can affect multiple organs, including the eyes.

Research has identified associations between non-alcoholic fatty liver disease (NAFLD) and conditions that impair eyesight, such as diabetic retinopathy, dry eye syndrome, and changes in retinal blood vessels.^[3][4] These are associations, not proven direct causal relationships. NAFLD frequently coexists with type 2 diabetes, obesity, hypertension, and metabolic syndrome, and it is these coexisting conditions that are the principal drivers of most retinal and ocular complications. It is therefore often difficult to attribute blurry vision solely to fatty liver disease without considering these overlapping factors.

It is important to note that there is no single, direct pathway by which fatty liver causes blurry vision in isolation. Rather, the shared metabolic environment that promotes fat accumulation in the liver also promotes vascular and inflammatory changes throughout the body, including within the delicate structures of the eye. Understanding this broader picture helps explain why patients with fatty liver disease are sometimes found to have eye problems that might otherwise seem unrelated to their liver diagnosis.

Note on terminology: NAFLD remains the term used in NICE guidance (NG49). Some international bodies now use the term metabolic dysfunction-associated steatotic liver disease (MASLD); these largely describe the same condition, and both terms may be encountered in clinical settings.

How does liver disease lead to vision problems?

Liver disease contributes to vision problems via vitamin A depletion, chronic inflammation affecting retinal microvasculature, and metabolic syndrome-related dry eye syndrome.

Liver disease is associated with vision problems primarily through systemic metabolic disruption, chronic inflammation, and nutritional deficiencies rather than through a single direct mechanism. The liver plays a central role in processing fats, regulating blood glucose, managing inflammation, and storing fat-soluble vitamins, including vitamin A. When liver function is compromised, each of these processes can be affected in ways that may ultimately reach the eyes.

One well-established pathway involves vitamin A deficiency. The liver stores the majority of the body's vitamin A, which is essential for producing rhodopsin, the pigment in the retina that enables vision in low-light conditions.^[6][7] In advanced liver disease, vitamin A stores can become depleted, leading to night blindness and, in severe cases, broader visual impairment.^[6][7] This is more commonly seen in cirrhosis than in early-stage fatty liver disease. If you are concerned about vitamin A levels, speak to your GP or specialist before taking any supplements: vitamin A is fat-soluble and can itself be harmful to the liver in excess, so supplementation should only be undertaken under medical supervision.^[7][8]

Chronic low-grade inflammation associated with NAFLD and NASH may also affect the microvasculature of the retina. Inflammatory cytokines and oxidative stress can damage small blood vessels, contributing to microvascular changes. However, the retinal complications most clearly linked to this process, including retinopathy and fluid leakage in the retina, are primarily driven by diabetes and chronic hyperglycaemia rather than by fatty liver disease directly. Where NAFLD and diabetes coexist, the risk of retinal damage is substantially higher.

Dry eye syndrome is another reported association. Studies suggest a link between metabolic syndrome and meibomian gland dysfunction, which can alter the stability of the tear film and lead to ocular surface discomfort and intermittent blurring.^[9][10] The precise mechanisms are still being investigated, and this should be regarded as a proposed rather than a proven relationship. Patients with fatty liver disease who notice persistent dryness, grittiness, or fluctuating vision should mention this to their GP, as it may warrant an ophthalmology referral.

What other symptoms usually appear alongside blurry vision?

Blurry vision in fatty liver disease is typically accompanied by fatigue, right-sided abdominal discomfort, dry eyes, and symptoms of coexisting diabetes such as increased thirst and frequent urination.

Blurry vision in the context of fatty liver disease rarely appears in isolation and is typically accompanied by a range of other systemic and hepatic symptoms. Recognising this broader symptom picture can help both patients and clinicians identify the underlying cause more accurately.

Common symptoms that may accompany blurry vision in people with fatty liver disease include:

• Fatigue and low energy: One of the most frequently reported symptoms of NAFLD, often described as persistent tiredness that does not improve with rest.

• Abdominal discomfort: A dull ache or feeling of fullness in the upper right abdomen, where the liver sits.

• Obesity and difficulty losing weight: Excess weight and insulin resistance are closely linked risk factors for fatty liver disease rather than direct symptoms of it, but they frequently coexist and contribute to the overall metabolic picture.

• Increased thirst and frequent urination: Suggestive of coexisting type 2 diabetes or pre-diabetes, which itself can cause retinal changes.

• Dry or gritty eyes: As noted above, tear film instability is associated with metabolic conditions including fatty liver disease.

• Skin changes: Yellowing of the skin or whites of the eyes (jaundice) in more advanced liver disease, or xanthelasma (fatty deposits around the eyelids), which can be associated with dyslipidaemia but may also occur with normal lipid levels.

In more advanced liver disease, symptoms such as swelling of the legs and abdomen, easy bruising, and confusion may also develop. Hepatic encephalopathy, caused by the build-up of toxins the liver can no longer process, primarily causes cognitive and neuromotor changes such as confusion, altered behaviour, and difficulty concentrating; visual disturbances may occur but are not a typical feature.^[12][13] If any of these more serious symptoms are present, prompt medical assessment is essential.

If you develop jaundice, seek urgent assessment from your GP or contact NHS 111 for advice on the same day.

When should you see a doctor about your eyes and liver health?

See your GP promptly if you have persistent blurry vision alongside liver or metabolic symptoms; sudden vision loss or eye pain requires same-day emergency assessment.

You should see your GP promptly if you experience persistent blurry vision alongside any symptoms that suggest liver or metabolic disease, rather than waiting to see whether symptoms resolve on their own. Early assessment allows for timely investigation and reduces the risk of complications in both the liver and the eyes.

Specific situations that warrant a GP appointment include:

• New or worsening blurry vision that is not explained by a recent change in glasses prescription.

• Blurry vision combined with increased thirst, frequent urination, or unexplained weight changes, which may indicate undiagnosed or poorly controlled diabetes.

• Persistent fatigue, right-sided abdominal discomfort, or abnormal liver function tests identified on routine blood tests.

• Dry, gritty, or uncomfortable eyes that do not respond to over-the-counter lubricating drops.

• Any yellowing of the skin or eyes, which requires urgent same-day assessment via your GP or NHS 111.

If you experience sudden loss of vision, a curtain or shadow across your visual field, severe eye pain, or visual disturbance accompanied by a severe headache, seek same-day assessment at an eye casualty department or accident and emergency. Contact NHS 111 if you are unsure which service to attend.

Your GP may arrange liver function tests, a fasting lipid profile, HbA1c (to check for diabetes), and an abdominal ultrasound. NICE guidance on NAFLD (NG49) recommends that people with suspected NAFLD and risk factors for fibrosis are assessed using a non-invasive fibrosis score such as the FIB-4 index or NAFLD fibrosis score in primary care, with referral to a specialist liver service for those at higher risk or where second-line assessment (such as enhanced liver fibrosis testing or elastography) is indicated.^[1][2] Referral to an ophthalmologist may be recommended if retinal changes are suspected.

Adults with type 2 diabetes should be enrolled in the NHS Diabetic Eye Screening Programme, which offers annual retinal photography to detect diabetic retinopathy at an early, treatable stage.^[15][16] If you have diabetes and are not yet enrolled, ask your GP practice to refer you.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review, which may be a useful starting point for those seeking initial guidance on metabolic health.

Lifestyle changes that support both liver and eye health

A Mediterranean-style diet, at least 150 minutes of weekly aerobic activity, alcohol reduction, and smoking cessation are the most evidence-based strategies for protecting both liver and eye health.

Adopting a balanced, evidence-based lifestyle is the most effective strategy for improving both liver health and reducing the risk of vision-related complications associated with fatty liver disease. NICE guidance on NAFLD (NG49) emphasises that weight management, dietary change, and physical activity form the cornerstone of treatment for most people with early-stage disease.

Diet: A Mediterranean-style diet, rich in vegetables, legumes, whole grains, oily fish, and olive oil, has the strongest evidence base for reducing liver fat and improving metabolic markers, as supported by NICE NG49 and the British Liver Trust.^[1][2] Reducing intake of ultra-processed foods, refined sugars, and saturated fats supports both liver function and cardiovascular health, which in turn protects retinal blood vessels. Colourful vegetables and fruits provide vitamins C and E, which support general eye health. If you are concerned about vitamin A or other fat-soluble vitamin levels, discuss this with your GP or specialist before taking supplements, as excess vitamin A can be harmful to the liver.

Physical activity: The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults.^[20][21] Regular exercise improves insulin sensitivity, reduces liver fat, and lowers systemic inflammation, all of which benefit ocular health. Even modest weight loss of 5 to 10 per cent of body weight has been shown in clinical studies to reduce liver fat significantly.^[17][18]

Alcohol: Alcohol is directly hepatotoxic and should be kept within NHS guidelines (no more than 14 units per week, spread across at least three days).^[22][23] People with established liver disease are often advised by their clinician to abstain entirely.

Smoking cessation: Smoking accelerates vascular damage and is an independent risk factor for age-related macular degeneration and retinal vascular disease. NHS Stop Smoking services offer free, evidence-based support.

Regular monitoring: The College of Optometrists recommends a sight test at least every two years for most adults, or more frequently if advised by your optometrist or ophthalmologist. Adults with diabetes should attend annual NHS Diabetic Eye Screening in addition to routine sight tests. Routine liver function blood tests allow early detection of changes, enabling timely intervention before complications develop.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. NG49 resources: MASLD assessment and management (PDF).
3. Non-alcoholic fatty liver disease (NAFLD).
4. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
5. Diabetic retinopathy.
6. Nyctalopia Due to Severe Liver Cirrhosis-induced Vitamin A Deficiency.
7. Vitamin A – Vitamins and minerals.
8. Lay Summary of the Statement on the effects of excess vitamin A on maternal health.
9. Gut-ocular surface axis in dry eye disease: phenotype-specific mechanisms, evidence, and microbiome-targeted interventions. Frontiers in Cellular and Infection Microbiology.
10. Meibomian Gland Assessment in Routine Ophthalmology Practice. Metabolites.
11. Exploring the overlooked risk: Ocular health and alterations in women with polycystic ovary syndrome. European Journal of Ophthalmology.
12. Hepatic Encephalopathy: Current Thoughts on Pathophysiology and Management. Current Neurology and Neuroscience Reports.
13. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation? Analytical Biochemistry.
14. Portosystemic encephalopathy. Handbook of Clinical Neurology.
15. Diabetic eye screening.
16. Diabetic eye screening: cohort management.
17. Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: A randomized controlled trial. JHEP Reports.
18. Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis. BMC Gastroenterology.
19. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. American Journal of Clinical Nutrition.
20. UK Chief Medical Officers' Physical Activity Guidelines.
21. Physical activity guidelines for adults aged 19 to 64.
22. Alcohol units.
23. The risks of drinking too much.
24. Smoking and the Long-term Incidence of Age-Related Macular Degeneration.
25. Smoking status and treatment outcomes of retinal vascular disease.
26. How often can I have a free NHS sight test?.

Frequently Asked Questions